Back to Journals » Journal of Blood Medicine » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile and Management of Toxicity of Selinexor and Belantamab Mafodotin for the Treatment of Triple Class Refractory Multiple Myeloma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,563 | Dovepress* | 4,759+ | 642 | 5,401 | |
PubMed Central* | 1,804 | 313 | 2,117 | ||
Totals | 6,563 | 955 | 7,518 | ||
*Since 1 July 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
14 | 0 | 0 | 0 | 7 | 7 |
View citations on PubMed Central and Google Scholar